Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.280
-0.060 (-1.38%)
Jul 3, 2025, 1:00 PM - Market closed
Cingulate Employees
Cingulate had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,259,689
Market Cap
18.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | -1 | -6.25% |
| Dec 31, 2021 | 16 | 4 | 33.33% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CING News
- 16 days ago - Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING) - Newsfile Corp
- 2 months ago - Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets - GlobeNewsWire
- 3 months ago - Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone) - GlobeNewsWire
- 3 months ago - Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved - GlobeNewsWire
- 6 months ago - Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000 - GlobeNewsWire
- 8 months ago - Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market - GlobeNewsWire
- 9 months ago - Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - GlobeNewsWire
- 10 months ago - Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301 - GlobeNewsWire